Feasibility of the TNM‐based staging system of ocular adnexal extranodal marginal zone lymphoma of mucosa‐associated lymphoid tissue (MALT lymphoma)
Open Access
- 14 December 2010
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 86 (3) , 262-266
Abstract
The American Joint Committee on Cancer has proposed the tumor, node, metastasis (TNM) staging system to overcome the limitations of the Ann Arbor staging system for ocular adnexal lymphoma. We performed this study to evaluate the feasibility of the TNM staging system for ocular adnexal extranodal marginal zone lymphoma of mucosa‐associated lymphoid tissue (OAML). The data form 66 total eyes from 54 patients with biopsy‐confirmed OAML according to World Health Organization classification were retrospectively analyzed. Using the TNM staging system, we reclassified all patients into two categories: (1) T1N0M0 stage group (n = 26), for patients with lymphoma involving only the conjunctiva; and (2) above T1N0M0 or bT1N0M0 stage group (n = 28), for patients with lymphoma extending to the orbit, eyelid, or adjacent structures, and/or bilateral OAML. After a 24‐month median follow‐up period for all patients, the T1N0M0 group revealed higher progression‐free survival (PFS) than the above T1N0M0 or the bT1N0M0 group (P = 0.041). In a separate analysis of only 50 patients categorized as Ann Arbor stage IE, the T1N0M0 group demonstrated higher PFS (100%) than the above T1N0M0 or the bT1N0M0 group (84.7%; P = 0.067). Our data show that the poor prognostic group classified as Ann Arbor stage IE can be further distinguished by using the TNM staging system. Thus, further studies to develop treatment strategies for reducing relapse after treatment for OAML should use the TNM staging system. Am. J. Hematol. 2011.Keywords
This publication has 19 references indexed in Scilit:
- A TNM-Based Clinical Staging System of Ocular Adnexal LymphomasArchives of Pathology & Laboratory Medicine, 2009
- Extranodal marginal zone lymphoma of the ocular adnexaBlood, 2009
- Therapeutic management of ocular adnexal MALT lymphomaExpert Opinion on Pharmacotherapy, 2007
- Prognosis for Patients in a Korean Population with Ocular Adnexal Lymphoproliferative LesionsOphthalmic Plastic & Reconstructive Surgery, 2007
- Revised Response Criteria for Malignant LymphomaJournal of Clinical Oncology, 2007
- The Clinical Characteristics and Treatment Results of Ocular Adnexal LymphomaKorean Journal of Ophthalmology, 2006
- Clinicopathologic analysis of ocular adnexal lymphomas: Extranodal marginal zone b‐cell lymphoma constitutes the vast majority of ocular lymphomas among Koreans and affects younger patientsAmerican Journal of Hematology, 2003
- The clinical utility of the Revised European-American Lymphoma (R.E.A.L.) Classification: Preliminary results of a prospective study in patients with non-Hodgkin's lymphoma from a single centreAnnals of Oncology, 1999
- REAL classification of malignant lymphomas in the republic of koreaCancer, 1998
- Lymphoid hyperplasia and malignant lymphoma occurring in the ocular adnexa (orbit, conjunctiva, and eyelids): A prospective multiparametric analysis of 108 cases during 1977 to 1987Human Pathology, 1990